News
-
-
-
-
-
PRESS RELEASE
Xlife Sciences AG Announces the Intended Listing of VERAXA Biotech AG on the NASDAQ Stock Exchange in the 2025 Fiscal Year
Xlife Sciences AG announces the intended listing of VERAXA Biotech AG on the NASDAQ Stock Exchange in the 2025 fiscal year, aiming to advance novel cancer therapies and create value for shareholders -
-
-
-
-